Induced pluripotent stem cells in disease modelling and drug discovery

RG Rowe, GQ Daley - Nature Reviews Genetics, 2019 - nature.com
The derivation of induced pluripotent stem cells (iPSCs) over a decade ago sparked
widespread enthusiasm for the development of new models of human disease, enhanced …

Current challenges of iPSC-based disease modeling and therapeutic implications

MX Doss, A Sachinidis - Cells, 2019 - mdpi.com
Induced pluripotent stem cell (iPSC)-based disease modelling and the cell replacement
therapy approach have proven to be very powerful and instrumental in biomedical research …

Modeling neoplastic disease with spheroids and organoids

M Zanoni, M Cortesi, A Zamagni, C Arienti… - Journal of hematology & …, 2020 - Springer
Cancer is a complex disease in which both genetic defects and microenvironmental
components contribute to the development, progression, and metastasization of disease …

Epidemiology and risk factors of osteosarcoma

LR Sadykova, AI Ntekim… - Cancer …, 2020 - Taylor & Francis
Osteosarcoma is a rare tumor diagnosed at any age; however younger age is a common risk
factor. In addition, multiple factors are believed to contribute to higher rates of osteosarcoma …

[HTML][HTML] The consequences of recurrent genetic and epigenetic variants in human pluripotent stem cells

PW Andrews, I Barbaric, N Benvenisty, JS Draper… - Cell Stem Cell, 2022 - cell.com
It is well established that human pluripotent stem cells (hPSCs) can acquire genetic and
epigenetic changes during culture in vitro. Given the increasing use of hPSCs in research …

[HTML][HTML] Promising applications of tumor spheroids and organoids for personalized medicine

Z Gilazieva, A Ponomarev, C Rutland, A Rizvanov… - Cancers, 2020 - mdpi.com
Simple Summary Presently, the investigation of the tumor is carried out using different
models. One of the promising areas is the creation of 3D tumor models, such as spheroids …

Applications of organoids for cancer biology and precision medicine

YH Lo, K Karlsson, CJ Kuo - Nature cancer, 2020 - nature.com
Organoid technologies enable the creation of in vitro physiologic systems that model tissues
of origin more accurately than classical culture approaches. Seminal characteristics of these …

LncRNA TUG1 sponges miR-204-5p to promote osteoblast differentiation through upregulating Runx2 in aortic valve calcification

C Yu, L Li, F **e, S Guo, F Liu, N Dong… - Cardiovascular …, 2018 - academic.oup.com
Aims Emerging evidence indicates that long non-coding RNAs (lncRNAs) play a vital role in
cardiovascular physiology and pathology. Although the lncRNA TUG1 is implicated in …

The H19 Long non-coding RNA in cancer initiation, progression and metastasis–a proposed unifying theory

E Raveh, IJ Matouk, M Gilon, A Hochberg - Molecular cancer, 2015 - Springer
The imprinted oncofetal long non-coding RNA (lncRNA) H19 is expressed in the embryo,
down-regulated at birth and then reappears in tumors. Its role in tumor initiation and …

The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy

L Liu, X An, Z Li, Y Song, L Li, S Zuo, N Liu… - Cardiovascular …, 2016 - academic.oup.com
Abstract Aims The H19 lncRNA, a highly abundant and conserved imprinted gene, has been
implicated in many essential biological processes and diseases. However, the function of …